Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
At close: 17 April at 4:00:00 pm GMT-4 ...
E-Mini Nasdaq 100 26841.25 354.00 1.34% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results